New studies require new criteria for critical appraisal;Ein neuer maßstab: Aktuelle studien verlangen veränderte beurteilungskriterlen

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 97, Issue 4-5, 2003, Pages 301-306

  Donner Banzhoff, Norbert ^a   Lelgemann, Monika ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

Bias (epidemiology); Evidence based medicine; Guidelines; Randomised controlled trials

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; PRACTICE GUIDELINE; RANDOMIZATION; STANDARD; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; CLINICAL TRIAL; HUMAN; METHODOLOGY; REPRODUCIBILITY; THERAPY; TREATMENT OUTCOME;

CLINICAL TRIALS; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; THERAPEUTICS; TREATMENT OUTCOME;

EID: 0037815269     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 324: 71-86
2. Dahlof B, Devereux RB, Kjeldsen SE, et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995-1003
3. Dept. of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre (1981) How to read clinical journals: I. Why to read them and how to start reading them critically. Can Med Assoc J 124: 555-558
4. Diener HC, Cunha L, Forbes C, et al. (1995) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143: 1-13
5. Diener HC (2002) Überlegene Wirksamkeit in effektivere Prävention umsetzen. ESPS 2. Beilage zum Dt. Ärzteblatt Ausgabe 36
6. Lancaster T, Weingarten M (1998) Critical appraisal. In Silagy C, Haines A (ed) Evidence Based Practice in Primary Care. London: BMJ Books
7. Lewis EJ, Hunsicker LG, Clarde WR, et al. (2001) for the Collaborative Study Group. Renoprotective Effect of the Angiotensin-receptor Antagonist Irbesartan in Patients with Nephropathy due to Type 2 Diabetes. N Engl J Med 345: 851-860
8. Moher D, Cook DJ, Eastwood S, et al. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 1896-1900
9. Moher D, Schulz KF, Altman D (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285: 1987-1991
10. Sackett DL (2001) Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinical-trialist is ever likely to need (or understand!). Can Med Assoc J 165: 1226-1237
11. The Canadian Tastk Force on the Periodic Health Examination (1994) The Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada.
12. The Dutch Trial Study Group (1991) A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients After a Transient Ischemic Attack or Minor Ischemic Stroke. N Engl J Med 325: 1261-1266